 PETACH TIKVA, Israel, Oct. 26, 2022 GLOBE NEWSWIRE -- PolyPid Ltd. Nasdaq: PYPD PolyPid or the Company, a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its third quarter 2022 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, November 9, 2022. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations. 